Drug intelligence / Profile preview

Lingjing Capsules

Development stage: Unknown
Lead developer: Jiangsu Tiansheng Pharmaceutical
Administration: Oral

Overview

Lingjing Capsules (灵精胶囊) is a traditional Chinese medicine (TCM) product developed and manufactured by Jiangsu Tiansheng Pharmaceutical. It is formulated as a health supplement primarily composed of extracts from *Ganoderma lucidum* (Lingzhi) and *Panax ginseng* (Ginseng). The product is designed to function as a general health tonic, with primary indications for enhancing the immune system and relieving physical fatigue. It is approved in China and is typically marketed as a "health food" (Blue Hat) product. The capsules are administered orally and are intended to replenish vital energy (Qi) and essence (Jing) according to TCM principles.

Brand names: Lingjing
Other names: 灵精胶囊

Targets

TBK1 (TANK binding kinase 1)STING (Stimulator of interferon genes protein)NF-κB

Beyond the preview

Go deeper on Lingjing Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingjing Capsules.

Explore the full profile